Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW (2005) Nature 436: 807-11 A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN (1988) Cell 52: 185-95 Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. Keller UB, Old JB, Dorsey FC, Nilsson JA, Nilsson L, MacLean KH, Chung L, Yang C, Spruck C, Boyd K, Reed SI, Cleveland JL (2007) EMBO J 26: 2562-74 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Serafeim A, Grafton G, Chamba A, Gregory CD, Blakely RD, Bowery NG, Barnes NM, Gordon J (2002) Blood 99: 2545-53 Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements. Zutter MM, Painter AA, Staatz WD, Tsung YL (1995) Blood 86: 3006-14 Id2 is dispensable for myc-induced lymphomagenesis. Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL (2004) Cancer Res 64: 7296-301 Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Huye LE, Nakazawa Y, Patel MP, Yvon E, Sun J, Savoldo B, Wilson MH, Dotti G, Rooney CM (2011) Mol Ther 19: 2239-48 The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. Meredith EJ, Holder MJ, Chamba A, Challa A, Drake-Lee A, Bunce CM, Drayson MT, Pilkington G, Blakely RD, Dyer MJ, Barnes NM, Gordon J (2005) FASEB J 19: 1187-9 Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Ivanisevic J, Zhu ZJ, Plate L, Tautenhahn R, Chen S, O'Brien PJ, Johnson CH, Marletta MA, Patti GJ, Siuzdak G (2013) Anal Chem 85: 6876-84 Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT (1999) Mol Cell Biol 19: 1651-60 The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis. Cardone M, Kandilci A, Carella C, Nilsson JA, Brennan JA, Sirma S, Ozbek U, Boyd K, Cleveland JL, Grosveld GC (2005) Mol Cell Biol 25: 2395-405 c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Gregory MA, Hann SR (2000) Mol Cell Biol 20: 2423-35 The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Chang DW, Claassen GF, Hann SR, Cole MD (2000) Mol Cell Biol 20: 4309-19 Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma. Niklinski J, Claassen G, Meyers C, Gregory MA, Allegra CJ, Kaye FJ, Hann SR, Zajac-Kaye M (2000) Mol Cell Biol 20: 5276-84 Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR, Hiebert SW (1999) Mol Cell Biol 19: 6566-74 A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV (1995) Mol Cell Biol 15: 4031-42 EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT (2001) Curr Top Microbiol Immunol 258: 153-60 Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Hande KR, Garrow GC (1993) Am J Med 94: 133-9 Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate. Berguig GY, Convertine AJ, Shi J, Palanca-Wessels MC, Duvall CL, Pun SH, Press OW, Stayton PS (2012) Mol Pharm 9: 3506-14 Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Borinstein SC, Xu M, Hawkins DS (2008) Pediatr Blood Cancer 50: 189
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.